Survival models for cost data: The forgotten additive approach

Statistics in Medicine

Volumn 27, Issue 18, 2008, Pages 3585-3597

  Pagano, Eva ^a   Petrinco, Michele ^a   Desideri, Alessandro ^b   Bigi, Riccardo ^c   Merletti, Franco ^a   Gregori, Dario ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b S Giacomo Hospital   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Aalen model; Myocardial infarction; Statistical methods; Survival models

Indexed keywords

ACUTE HEART INFARCTION; ARTICLE; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; ECG ABNORMALITY; EXERCISE ELECTROCARDIOGRAPHY; HEALTH CARE COST; HEART EJECTION FRACTION; HOSPITAL DISCHARGE; HUMAN; MONTE CARLO METHOD; PROGNOSIS; REGRESSION ANALYSIS; RISK FACTOR; STATISTICAL ANALYSIS; STATISTICAL MODEL; STRESS ECHOCARDIOGRAPHY; SURVIVAL RATE;

COSTS AND COST ANALYSIS; HUMANS; MODELS, STATISTICAL; MONTE CARLO METHOD; MYOCARDIAL INFARCTION; SURVIVAL ANALYSIS;

EID: 48249139863     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.3215     Document Type: Article

References (22)

1. Dudley RA, Harrell Jr FE, Smith LR, Mark DB, Califf RM, Pryor DB, Glower D, Lipscomb J, Hlatky M. Comparison of analytic models for estimating the effect of clinical factors on the cost of coronary artery bypass graft surgery. Journal of Clinical Epidemiology 1993; 46:261-271.
2. Etzioni RD, Feuer EJ, Sullivan SD, Lin D, Hu C, Ramsey SD. On the use of survival analysis techniques to estimate medical care costs. Journal of Health Economics 1999; 18:365-380.
3. Basu A, Manning WG, Mullahy J. Comparing alternative models: log vs Cox proportional hazard? Health Economics 2004; 13:749-765.
4. Aalen OO. A linear regression model for the analysis of life times. Statistics in Medicine 1989; 8:907-925.
5. Aalen OO. Further results on the non-parametric linear regression model in survival analysis. Statistics in Medicine 1993; 12:1569-1588.
6. Harrell FE. Regression Modelling Strategies. Springer: New York, 2001.
7. Barthel FM, Babiker A, Royston P, Parmar MK. Evaluation of sample size and power for multi-arm survival trials allowing for non-uniform accrual, non-proportional hazards, loss to follow-up and cross-over. Statistics in Medicine 2006; 25:2521-2542.
8. The R Development Core Team. R 2.1.1 - A Language and Environment, 2005. (Available from: http://cran.r-project.org/.)
9. Scheike T, Martinussen T. Package: Timereg. Additive Semiparametric Timevarying Regression, 2004. (Available from: http://cran.r-project.org/.)
10. Martinussen T, Scheike TH. Dynamic Regression Models for Survival Data. Springer: New York, 2006.
11. Harrell FE. Package: Design. Functions for Biostatistical/ Epidemiologic Applications, 2005. (Available from: http://cran.r-project.org/.)
12. Desideri A, Fioretti PM, Cortigiani L, Gregori D, Coletta C, Vigna C, Tota F, Rambaldi R, Bax J, Celegon L, Bigi R, Picano E. Cost of strategies after myocardial infarction (COSTAMI): a multicentre, international, randomized trial for cost-effective discharge after uncomplicated myocardial infarction. European Heart Journal 2003; 24:1630-1639.
13. Hall W, Wellner J. Confidence bands for a survival curve from censored data. Biometrika 1980; 67:133-143.
14. Lin D, Feuer E, Etzioni R, Wax Y. Estimating medical costs from incomplete follow up data. Biometrics 1997; 53:419-434.
15. Lin D. Linear regression analysis of censored medical costs. Biostatistics 2000; 1:35-47.
16. Lin DY. Regression analysis of incomplete medical cost data. Statistics in Medicine 2003; 22:1181-1200.
17. Bang H, Tsiatis A. Estimating medical cost with censored data. Biometrika 2000; 87:329-343.
18. Bang H, Tsiatis AA. Median regression with censored cost data. Biometrics 2002; 58:643-649.
19. Zhao H, Tian L. On estimating medical cost and incremental cost-effectiveness ratios with censored data. Biometrics 2001; 57:1002-1008.
20. Tian L, Huang J. A two-part model for censored medical cost data. Statistics in Medicine 2007; 26:4273-4292.
21. Liu L, Wolfe RA, Kalbfleisch JD. A shared random effects model for censored medical costs and mortality. Statistics in Medicine 2007; 26:139-155.
22. Stevens JW, O'Hagan A, Miller P. Case study in the Bayesian analysis of a cost-effectiveness trial in the evaluation of health care technologies: depression. Pharmaceutical Statistics 2003; 2:51-68.